High Serum PD-L1 Levels Are Associated with Poor Survival in Urothelial Cancer Patients Treated with Chemotherapy and Immune Checkpoint Inhibitor Therapy

Ulrich Krafft, Csilla Oláh, Henning Reis, +12

Cancers

Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancer

Ulrich Krafft, Stephan Tschirdewahn, Nina N. Harke, +10

Urologic Oncology Seminars and Original Investigations

Cisplatin ResistanceUrologyOncologyGenitourinary CancerMedicine +5

Janus-Faced Nature of Light in the Cold Acclimation Processes of Maize

Gabriella Szalai, Imre Majláth, Magda Pál, +6

Frontiers in Plant Science

MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer Patients

Tibor Szarvas, Michèle J. Hoffmann, Csilla Oláh, +9

Diagnostics

Cisplatin ResistanceTumor BiologyChemotherapy ResistanceUrologyGenitourinary Cancer +12

Gut microbiome composition: link between sports performance and protein absorption?

Péter Fritz, Réka Fritz, Pál Bóday, +4

Journal of the International Society of Sports Nutrition

ON THE BIOSYNTHESIS OF PILOCARPINE

E. Brochmann‐Hanssen, Michely Lopes Nunes, Csilla Oláh

Planta Medica

BiologyBiosynthesisMedicineCut Stem MethodSecondary Metabolite +6

Prevalence of APC and PTEN Alterations in Urachal Cancer

Nikolett Nagy, Henning Reis, Boris Hadaschik, +23

Pathology & Oncology Research

Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas

Melinda Váradi, Nikolett Nagy, Henning Reis, +23

Cancer Medicine

STIP1 Tissue Expression Is Associated with Survival in Chemotherapy-Treated Bladder Cancer Patients

Ulrich Krafft, Stephan Tschirdewahn, Nina N. Harke, +9

Pathology & Oncology Research

UrologyOncologyGenitourinary CancerMedicinePathology +5

Predictive value of molecular subtypes and <i>APOBEC3G</i> for adjuvant chemotherapy in urothelial bladder cancer

Csilla Oláh, Henning Reis, Michèle J. Hoffmann, +12

Cancer Medicine